73 In Development - Target not disclosed
73 In Development
Target not disclosed

Stage: Search & Match


Status: In development
Statistics
Overview

Number of patients

Drugs available on market


Drugs approved treatment

 


Commonly used drugs

Gender of the patients

Male
Female

Age distribution

Pediatric Patient
Adult Patient
Elderly Patient

Geographical distribution

These data are not available at the moment.
We are working on obtaining the most accurate information
about the geographical distribution of the disease.




What's inside

Documentation on DVDs

The Documentation you will receive upon signature of a Confidentiality Agreement and for due-diligence purposes is divided in 6 DVDs, according to the specific competence areas of evaluation:
Medicinal Product Candidate (Peptide)
Disease
Development
IP & Legal
Financial Information
Offered Services
 
For each area, you will find a detailed and complete information, with all literature references, on
 
1 - peptide and its characteristics, previous uses in pre-clinical and clinical and the available and developed CMC information;
2 - disease characteristics and mechanism of action;
3 - scientific and medical rationale;
4 - a complete overview of development activities already initiated or completed and a detailed development plan for the next steps;
5 - a complete information and copy of documentation regarding the intellectual property status and the orphan drug designation situation;
6 - the standard agreements for in-licensing and other collaborations;
7 - a detailed financial information on the disease market and detailed budget for developing the drug until marketing authorization;
8 - description of all services offered by Mondobiotech on the project